Violet Zhu
banner
vzhu1.bsky.social
Violet Zhu
@vzhu1.bsky.social
ID/AMS Pharmacist, PhD Student 💊🆔🦠🧫 @ncicancer.bsky.social @University of Melbourne #TxID #IDSky
Reposted by Violet Zhu
You've Got a Friend in Me: Curbside Questions Infectious Diseases Clinicians Ask Infectious Diseases Pharmacists

✅ Just Accepted
#IDSky
You've Got a Friend in Me: Curbside Questions Infectious Diseases Clinicians Ask Infectious Diseases Pharmacists
This multicenter study highlights the critical role of ID pharmacists in supporting ID consult services, with 89% of 1,518 curbside inquiries from ID clinicians resulting in clinical management changes as recommended by the pharmacist. These findings emphasize the necessity of ID pharmacists in optimizing multidisciplinary patient care.
doi.org
June 1, 2025 at 8:43 PM
Happy Infectious Diseases Pharmacists Day to my colleagues, mentors, and clinician-researcher heroes #IDPharmacistsDay #SIDPAdvocacy @adphaau.bsky.social @sidpharm.bsky.social @ncicancer.bsky.social
May 21, 2025 at 11:48 PM
Reposted by Violet Zhu
🆕️🔥Systematic review and meta-analysis of randomized controlled trials #infection
9 RCTs, N:1439
Prophylactic vs preemptive strategy for the prevention of CMV disease in solid organ transplant recipients #idsky
link.springer.com/article/10.1...
Prophylactic vs preemptive strategy for the prevention of CMV disease in solid organ transplant recipients: systematic review and meta-analysis of randomized controlled trials - Infection
Purpose Cytomegalovirus (CMV) is associated with significant morbidity and mortality among solid organ transplant (SOT) recipients. Strategies for CMV prevention include universal prophylaxis or preem...
link.springer.com
November 25, 2024 at 10:27 AM
Reposted by Violet Zhu
Both letermovir & maribavir can be perpetrator or victim of a drug–drug interaction
🆕️🔥 #CPK
Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir & Maribavir: Guidance for Clinicians #idsky
✨️tables✨️ #bookmark
link.springer.com/article/10.1...
Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians - Clinical Pharmacokinetics
Letermovir and maribavir have demonstrated efficacy in the prevention and treatment, respectively, of immunosuppressed patients with cytomegalovirus (CMV) infection and disease. These patients often h...
link.springer.com
November 15, 2024 at 3:54 PM
#Forbes2024 was so cool (although this could be my antiviral bias?)! Exciting stuff happening across the world and in Vic in the TxID space. 🆔👏🏻 I could listen to Forbes Fellow @kottonnelson.bsky.social talk all day, such an engaging (and funny) presenter! Well done everyone who made it happen!
November 15, 2024 at 12:17 PM